SCHEMBL2946185

SCHEMBL2946185

O=C1OC2CCCCCCCCCCC1CCCC2

nearest known ligand 0.38

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CEL P19835 2/20 0.38
DAO P14920 2/20 0.38
TDO2 P48775 1/20 0.32
MAOA P21397 1/20 0.31
MAOB P27338 1/20 0.31
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10731203 1.00 CEL (0.38) CELDAOTDO2MAOAMAOB
SCHEMBL11788351 1.00 CEL (0.38) CELDAOTDO2MAOAMAOB
SCHEMBL4320756 1.00 CEL (0.38) CELDAOTDO2MAOAMAOB
SCHEMBL3254629 0.98 CEL (0.37) CELDAOTDO2MAOAMAOB
SCHEMBL11698690 0.95 CEL (0.36) CELDAOTDO2
SCHEMBL19497234 0.88 CEL (0.31) CEL
SCHEMBL110922 0.81
SCHEMBL14491689 0.78
SCHEMBL3936372 0.78
SCHEMBL3947361 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3089730-A1 DEODORANT COMPOSITIONS HAVING ANTIBACTERIAL AND ODOR BLOCKING PROPERTIES AND RELATED METHODS The Dial Corporation (US) 2016-11-09 EP disclosed
US-9381142-B2 Olfactory adaptation and cross-adapting agents to reduce the perception of body odors MONELL CHEMICAL SENSES CENTER (US) 2016-07-05 US disclosed
WO-2015102915-A1 DEODORANT COMPOSITIONS HAVING ANTIBACTERIAL AND ODOR BLOCKING PROPERTIES AND RELATED METHODS THE DIAL CORPORATION (US) 2015-07-09 WO disclosed
US-20150182436-A1 DEODORANT COMPOSITIONS HAVING ANTIBACTERIAL AND ODOR BLOCKING PROPERTIES AND METHODS FOR USING THE SAME THE DIAL CORPORATION 2015-07-02 US disclosed
EP-2581077-A2 Olfactory adaption and cross-adapting agents to reduce the perception of body odors Symrise AG (DE) 2013-04-17 EP disclosed
US-20100254927-A1 OLFACTORY ADAPTATION AND CROSS-ADAPTING AGENTS TO REDUCE THE PERCEPTION OF BODY ODORS MONELL CHEMICAL SENSES CENTER (US) 2010-10-07 US disclosed
US-7763238-B2 Olfactory adaptation and cross-adapting agents to reduce the perception of body odors MONELL CHEMICAL SENSES CENTER (US) 2010-07-27 US disclosed
EP-1474095-A4 OLFACTORY ADAPTATION AND CROSS-ADAPTING AGENTS TO REDUCE THE PERCEPTION OF BODY ODORS MONELL CHEMICAL SENSES CENTRE (US) 2007-11-28 EP disclosed
US-20070020210-A1 Methods of reducing the perception of body odors with olfactory adaptation and cross-adapting agents MONELL CHEMICAL SENSES CENTER 2007-01-25 US disclosed
EP-1474095-A1 OLFACTORY ADAPTATION AND CROSS-ADAPTING AGENTS TO REDUCE THE PERCEPTION OF BODY ODORS MONELL CHEMICAL SENSES CENTER (US) 2004-11-10 EP disclosed
US-20030152538-A1 Olfactory adaptation and cross-adapting agents to reduce the perception of body odors SYMRISE INC. 2003-08-14 US disclosed
WO-2003061609-A1 OLFACTORY ADAPTATION AND CROSS-ADAPTING AGENTS TO REDUCE THE PERCEPTION OF BODY ODORS MONELL CHEMICAL SENSES CENTER (US) 2003-07-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150182436-A1 DEODORANT COMPOSITIONS HAVING ANTIBACTERIAL AND ODOR BLOCKING PROPERTIES AND METHODS FOR USING THE SAME LPO, TYR, DDO CEL 1873/4885DAO 5/4885TDO2 58/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.